SCI Pharmtech, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 341.78 million compared to TWD 188.02 million a year ago. Net income was TWD 63.44 million compared to TWD 41.17 million a year ago.

Basic earnings per share from continuing operations was TWD 0.5956 compared to TWD 0.3822 a year ago. Diluted earnings per share from continuing operations was TWD 0.5867 compared to TWD 0.3822 a year ago.